Effector T helper cell subsets in inflammatory bowel diseases

Tanbeena Imam, Sungtae Park, Mark Kaplan, Matthew R. Olson

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

The gastrointestinal tract is a site of high immune challenge, as it must maintain a delicate balance between tolerating luminal contents and generating an immune response toward pathogens. CD4+ T cells are key in mediating the host protective and homeostatic responses. Yet, CD4+ T cells are also known to be the main drivers of inflammatory bowel disease (IBD) when this balance is perturbed. Many subsets of CD4+ T cells have been identified as players in perpetuating chronic intestinal inflammation. Over the last few decades, understanding of how each subset of Th cells plays a role has dramatically increased. Simultaneously, this has allowed development of therapeutic innovation targeting specific molecules rather than broad immunosuppressive agents. Here, we review the emerging evidence of how each subset functions in promoting and sustaining the chronic inflammation that characterizes IBD.

Original languageEnglish (US)
Article number1212
JournalFrontiers in Immunology
Volume9
Issue numberJUN
DOIs
StatePublished - Jun 1 2018

Fingerprint

T-Lymphocyte Subsets
Inflammatory Bowel Diseases
Inflammation
T-Lymphocytes
Immunosuppressive Agents
Gastrointestinal Tract
Therapeutics

Keywords

  • Crohn's disease
  • Inflammatory bowel disease
  • Inflammatory cytokines
  • T helper cells
  • Transcription factors
  • Ulcerative colitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Effector T helper cell subsets in inflammatory bowel diseases. / Imam, Tanbeena; Park, Sungtae; Kaplan, Mark; Olson, Matthew R.

In: Frontiers in Immunology, Vol. 9, No. JUN, 1212, 01.06.2018.

Research output: Contribution to journalReview article

Imam, Tanbeena ; Park, Sungtae ; Kaplan, Mark ; Olson, Matthew R. / Effector T helper cell subsets in inflammatory bowel diseases. In: Frontiers in Immunology. 2018 ; Vol. 9, No. JUN.
@article{1216ba0934b2488a9f088c811a7b0258,
title = "Effector T helper cell subsets in inflammatory bowel diseases",
abstract = "The gastrointestinal tract is a site of high immune challenge, as it must maintain a delicate balance between tolerating luminal contents and generating an immune response toward pathogens. CD4+ T cells are key in mediating the host protective and homeostatic responses. Yet, CD4+ T cells are also known to be the main drivers of inflammatory bowel disease (IBD) when this balance is perturbed. Many subsets of CD4+ T cells have been identified as players in perpetuating chronic intestinal inflammation. Over the last few decades, understanding of how each subset of Th cells plays a role has dramatically increased. Simultaneously, this has allowed development of therapeutic innovation targeting specific molecules rather than broad immunosuppressive agents. Here, we review the emerging evidence of how each subset functions in promoting and sustaining the chronic inflammation that characterizes IBD.",
keywords = "Crohn's disease, Inflammatory bowel disease, Inflammatory cytokines, T helper cells, Transcription factors, Ulcerative colitis",
author = "Tanbeena Imam and Sungtae Park and Mark Kaplan and Olson, {Matthew R.}",
year = "2018",
month = "6",
day = "1",
doi = "10.3389/fimmu.2018.01212",
language = "English (US)",
volume = "9",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "JUN",

}

TY - JOUR

T1 - Effector T helper cell subsets in inflammatory bowel diseases

AU - Imam, Tanbeena

AU - Park, Sungtae

AU - Kaplan, Mark

AU - Olson, Matthew R.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - The gastrointestinal tract is a site of high immune challenge, as it must maintain a delicate balance between tolerating luminal contents and generating an immune response toward pathogens. CD4+ T cells are key in mediating the host protective and homeostatic responses. Yet, CD4+ T cells are also known to be the main drivers of inflammatory bowel disease (IBD) when this balance is perturbed. Many subsets of CD4+ T cells have been identified as players in perpetuating chronic intestinal inflammation. Over the last few decades, understanding of how each subset of Th cells plays a role has dramatically increased. Simultaneously, this has allowed development of therapeutic innovation targeting specific molecules rather than broad immunosuppressive agents. Here, we review the emerging evidence of how each subset functions in promoting and sustaining the chronic inflammation that characterizes IBD.

AB - The gastrointestinal tract is a site of high immune challenge, as it must maintain a delicate balance between tolerating luminal contents and generating an immune response toward pathogens. CD4+ T cells are key in mediating the host protective and homeostatic responses. Yet, CD4+ T cells are also known to be the main drivers of inflammatory bowel disease (IBD) when this balance is perturbed. Many subsets of CD4+ T cells have been identified as players in perpetuating chronic intestinal inflammation. Over the last few decades, understanding of how each subset of Th cells plays a role has dramatically increased. Simultaneously, this has allowed development of therapeutic innovation targeting specific molecules rather than broad immunosuppressive agents. Here, we review the emerging evidence of how each subset functions in promoting and sustaining the chronic inflammation that characterizes IBD.

KW - Crohn's disease

KW - Inflammatory bowel disease

KW - Inflammatory cytokines

KW - T helper cells

KW - Transcription factors

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=85047876048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047876048&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2018.01212

DO - 10.3389/fimmu.2018.01212

M3 - Review article

AN - SCOPUS:85047876048

VL - 9

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - JUN

M1 - 1212

ER -